Vicarious Surgical (RBOT) Other Non-Current Assets (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Other Non-Current Assets came in at $936000.0 in Q4 2025, little changed year-on-year from $936000.0 in Q4 2024, and little changed on a QoQ basis from $936000.0 in Q3 2025.
Vicarious Surgical (RBOT) Other Non-Current Assets (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Other Non-Current Assets data on file, last reported at $936000.0 in Q4 2025.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $936000.0 in Q4 2025; TTM through Dec 2025 was $936000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $936000.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $936000.0, roughly flat from $936000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for RBOT reached as high as $171.2 million in Q4 2021 and fell as low as $31000.0 in Q1 2025.
- Historically, Other Non-Current Assets has averaged $28.5 million across 5 years, with a median of $936000.0 in 2022.
- Across the five-year window, Other Non-Current Assets surged 171096.0% in 2021 and slumped 99.95% in 2022, its largest moves.
- Year by year, Other Non-Current Assets stood at $171.2 million in 2021, then slumped by 99.95% to $92000.0 in 2022, then jumped by 917.39% to $936000.0 in 2023, then changed by 0.0% to $936000.0 in 2024, then changed by 0.0% to $936000.0 in 2025.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $936000.0 in Q4 2025, $936000.0 in Q3 2025, and $936000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | 936,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 936,000.00 |
| Sep 30, 2025 | 936,000.00 |
| Jun 30, 2025 | 936,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 936,000.00 |
| Sep 30, 2024 | 936,000.00 |
| Jun 30, 2024 | 936,000.00 |
| Mar 31, 2024 | 105,000.00 |
| Dec 31, 2023 | 936,000.00 |
| Sep 30, 2023 | 146,000.00 |
| Jun 30, 2023 | 180,000.00 |
| Mar 31, 2023 | 97.21 Mn |
| Dec 31, 2022 | 92,000.00 |
| Sep 30, 2022 | 125.22 Mn |
| Jun 30, 2022 | 139.16 Mn |
| Mar 31, 2022 | 936,000.00 |
| Dec 31, 2021 | 171.20 Mn |
| Sep 30, 2021 | 622,000.00 |
| Jun 30, 2021 | 622,000.00 |
| Dec 31, 2020 | 100,000.00 |